abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Operating Expenses
-$77.94M
TTM · Period ending: · USD
HQL Operating Expenses
Latest reported-$77.94Mperiod ending
Latest reported-$77.94Mperiod ending
HQL TTM Operating Expenses ($520.00K → -$77.94M)
TTM operating expenses
High-resolution chart · PNG
HQL operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| -77,937,784 | |
| -54,832,365 | |
| 107,227,968 | |
| 47,191,828 | |
| 58,955,346 | |
| 56,275,611 | |
| 17,870,037 | |
| 15,015,237 | |
| 115,810 | |
| 90,950 | |
| 2,706,218 | |
| 5,379,453 | |
| 8,149,031 | |
| 10,912,558 | |
| 8,322,262 | |
| 5,659,806 | |
| 2,901,062 | |
| 193,536 | |
| 204,052 | |
| 268,620 | |
| 265,330 | |
| 230,344 | |
| 237,354 | |
| 159,651 | |
| 21,819,713 | |
| 75,556,860 | |
| 76,173,460 | |
| 76,835,597 | |
| 55,517,167 | |
| 2,139,999 | |
| 1,844,999 | |
| 1,549,998 | |
| 1,564,999 | |
| 1,579,999 | |
| 1,684,999 | |
| 1,789,999 | |
| 1,734,999 | |
| 1,679,999 | |
| 1,525,000 | |
| 1,370,000 | |
| 1,320,000 | |
| 1,270,000 | |
| 1,195,000 | |
| 1,120,000 | |
| 1,110,000 | |
| 1,100,000 | |
| 1,070,000 | |
| 1,040,000 | |
| 865,000 | |
| 690,000 | |
| 580,000 | |
| 470,000 | |
| 495,000 | |
| 519,999 |